PTC Therapeutics, Inc. (PTCT): Free Cash Flow
$702.34M
Year ended 2025-12-31
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $702.34M | n/m | 2026-02-19, From 2025-01-01 |
| 2024-12-31 | -$114.19M | n/m | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | -$186.86M | n/m | 2026-02-19, From 2023-01-01 |
| 2022-12-31 | -$388.67M | n/m | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | -$279.55M | n/m | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | -$211.91M | n/m | 2023-02-21, From 2020-01-01 |
| 2019-12-31 | -$112.40M | n/m | 2022-02-22, From 2019-01-01 |
| 2018-12-31 | -$34.74M | n/m | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | -$13.16M | n/m | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | -$105.34M | n/m | 2019-03-01, From 2016-01-01 |
| 2015-12-31 | -$127.06M | n/m | 2018-03-06, From 2015-01-01 |
| 2014-12-31 | -$61.94M | n/m | 2017-03-16, From 2014-01-01 |
| 2013-12-31 | -$47.77M | n/m | 2016-02-29, From 2013-01-01 |
| 2012-12-31 | -$48.12M | n/m | 2015-03-02, From 2012-01-01 |
| 2011-12-31 | -$20.93M | n/a | 2014-03-06, From 2011-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| PTC Therapeutics, Inc. (PTCT) | 2025-12-31 | $702.34M | n/m |
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $9.87M | -76.4% |
| Alkermes plc. (ALKS) | 2025-12-31 | $480.33M | +18.4% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | -$307.45M | n/m |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | -$93.00M | n/m |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $246.45M | +1.3% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $105.15M | -33.1% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $269.93M | +11.0% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | -$190.02M | n/m |
Compare PTCT, PAHC, ALKS, SRPT side by side · Screen every company in Pharmaceutical Preparations ↗